File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/prot.10270
- Scopus: eid_2-s2.0-0037235881
- PMID: 12471601
- WOS: WOS:000180131100008
- Find via
Supplementary
-
Bookmarks:
- CiteULike: 3
- Citations:
- Appears in Collections:
Article: Virtual screening to enrich hit lists from high-throughput screening: A case study on small-molecule inhibitors of angiogenin
Title | Virtual screening to enrich hit lists from high-throughput screening: A case study on small-molecule inhibitors of angiogenin |
---|---|
Authors | |
Keywords | Angiogenin Consensus scoring Enrichment Enzyme inhibitor False positives High-throughput screening Ligand docking Ribonuclease Virtual screening |
Issue Date | 2003 |
Citation | Proteins: Structure, Function And Genetics, 2003, v. 50 n. 1, p. 81-93 How to Cite? |
Abstract | "Hit lists" generated by high-throughput screening (HTS) typically contain a large percentage of false positives, making follow-up assays necessary to distinguish active from inactive substances. Here we present a method for improving the accuracy of HTS hit lists by computationally based virtual screening (VS) of the corresponding chemical libraries and selecting hits by HTS/VS consensus. This approach was applied in a case study on the target-enzyme angiogenin, a potent inducer of angiogenesis. In conjunction with HTS of the National Cancer Institute Diversity Set and ChemBridge DIVERSet E (∼18,000 compounds total), VS was performed with two flexible library docking/scoring methods, DockVision/Ludi and GOLD. Analysis of the results reveals that dramatic enrichment of the HTS hit rate can be achieved by selecting compounds in consensus with one or both of the VS functions. For example, HTS hits ranked in the top 2% by GOLD included 42% of the true hits, but only 8% of the false positives; this represents a sixfold enrichment over the HTS hit rate. Notably, the HTS/VS method was effective in selecting out inhibitors with midmicromolar dissociation constants typical of leads commonly obtained in primary screens. © 2002 Wiley-Liss, Inc. |
Persistent Identifier | http://hdl.handle.net/10722/157352 |
ISSN | 2023 Impact Factor: 3.2 2023 SCImago Journal Rankings: 1.086 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jenkins, JL | en_US |
dc.contributor.author | Kao, RYT | en_US |
dc.contributor.author | Shapiro, R | en_US |
dc.date.accessioned | 2012-08-08T08:49:09Z | - |
dc.date.available | 2012-08-08T08:49:09Z | - |
dc.date.issued | 2003 | en_US |
dc.identifier.citation | Proteins: Structure, Function And Genetics, 2003, v. 50 n. 1, p. 81-93 | en_US |
dc.identifier.issn | 0887-3585 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/157352 | - |
dc.description.abstract | "Hit lists" generated by high-throughput screening (HTS) typically contain a large percentage of false positives, making follow-up assays necessary to distinguish active from inactive substances. Here we present a method for improving the accuracy of HTS hit lists by computationally based virtual screening (VS) of the corresponding chemical libraries and selecting hits by HTS/VS consensus. This approach was applied in a case study on the target-enzyme angiogenin, a potent inducer of angiogenesis. In conjunction with HTS of the National Cancer Institute Diversity Set and ChemBridge DIVERSet E (∼18,000 compounds total), VS was performed with two flexible library docking/scoring methods, DockVision/Ludi and GOLD. Analysis of the results reveals that dramatic enrichment of the HTS hit rate can be achieved by selecting compounds in consensus with one or both of the VS functions. For example, HTS hits ranked in the top 2% by GOLD included 42% of the true hits, but only 8% of the false positives; this represents a sixfold enrichment over the HTS hit rate. Notably, the HTS/VS method was effective in selecting out inhibitors with midmicromolar dissociation constants typical of leads commonly obtained in primary screens. © 2002 Wiley-Liss, Inc. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Proteins: Structure, Function and Genetics | en_US |
dc.subject | Angiogenin | - |
dc.subject | Consensus scoring | - |
dc.subject | Enrichment | - |
dc.subject | Enzyme inhibitor | - |
dc.subject | False positives | - |
dc.subject | High-throughput screening | - |
dc.subject | Ligand docking | - |
dc.subject | Ribonuclease | - |
dc.subject | Virtual screening | - |
dc.subject.mesh | Binding Sites | en_US |
dc.subject.mesh | Computational Biology - Methods | en_US |
dc.subject.mesh | Computer Simulation | en_US |
dc.subject.mesh | Databases, Factual | en_US |
dc.subject.mesh | Enzyme Inhibitors - Analysis - Chemistry - Metabolism | en_US |
dc.subject.mesh | Ligands | en_US |
dc.subject.mesh | Models, Molecular | en_US |
dc.subject.mesh | Reproducibility Of Results | en_US |
dc.subject.mesh | Ribonuclease, Pancreatic - Antagonists & Inhibitors - Chemistry - Metabolism | en_US |
dc.title | Virtual screening to enrich hit lists from high-throughput screening: A case study on small-molecule inhibitors of angiogenin | en_US |
dc.type | Article | en_US |
dc.identifier.email | Kao, RYT:rytkao@hkucc.hku.hk | en_US |
dc.identifier.authority | Kao, RYT=rp00481 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1002/prot.10270 | en_US |
dc.identifier.pmid | 12471601 | en_US |
dc.identifier.scopus | eid_2-s2.0-0037235881 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0037235881&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 50 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 81 | en_US |
dc.identifier.epage | 93 | en_US |
dc.identifier.isi | WOS:000180131100008 | - |
dc.identifier.scopusauthorid | Jenkins, JL=7402867712 | en_US |
dc.identifier.scopusauthorid | Kao, RYT=7101675499 | en_US |
dc.identifier.scopusauthorid | Shapiro, R=7403082810 | en_US |
dc.identifier.citeulike | 478680 | - |
dc.identifier.issnl | 0887-3585 | - |